23andMe snagged $250,000 from the National Institutes of Health to study populations that are underrepresented in current research, such as African Americans and Asians. The Silicon Valley-based genetics company is looking for associations with disease via a technique called “admixture mapping.” Admixed groups are those with both European and non-European ancestry. This isn’t 23andMe’s first NIH grant; its database of 1.2 million people’s DNA has proven to be an attractive prospect to medical researchers. CF
collectionsInnovation FestivalCurrent Issue
World Changing Ideas
New workplaces, new food sources, new medicine--even an entirely new economic system.
The major tech ecosystems that battle for our attention and dollars.
What’s next for hardware, software, and services.
The brave new world of automation, from AI to drones.
How our urban centers are building toward the future.
Most Creative People
See members of our Most Creative People in Business community: leaders who are shaping the future of business in creative ways.
An award-winning team of journalists, designers, and videographers who tell brand stories through Fast Company's distinctive lens.